Recorded Webinar from Nov 9, 2017

Assessing the immunogenicity of biopharmaceuticals

Immunogenicity of therapeutic biopharmaceuticals can impact both the efficacy and the safety of the product. Assessment of anti-drug antibodies (ADAs) as well as neutralizing antibodies (NAbs) is a fundamental part of immunogenicity testing. 

By listening to this webinar, you will learn:

• how the Gyrolab™ platform automates drug-tolerant ADA immunoassays in a time-efficient way using small volumes of patient samples and reagents
  
• how iLite® Assay Ready reporter gene cell lines are designed to overcome limitations of conventional cell-based assays in the assessment of neutralizing antibodies

Speakers:

Cecilia Bill,
Application Scientist, Gyros Protein Technologies AB

Frida Pauly,
Manager Biopharma Solutions, Euro Diagnostica AB

If you have problems to view the webinar please contact maritha.lundin@gyrosproteintech.com